Ziff Davis (NASDAQ:ZD) announced Tuesday that it has reached a definitive agreement to divest its Connectivity business to Accenture in an all-cash transaction valued at $1.2 billion.
Prime Medicine (NASDAQ:PRME) reported full-year 2025 financial results on Tuesday, signaling a strategic shift toward commercial-stage readiness as its "search-and-replace" gene editing platform achieves its first human clinical validations.
Antalpha (NASDAQ:ANTA) posted an explosive fourth quarter on Tuesday, capitalizing on a sharp rise in institutional demand for Bitcoin-backed financing and a timely strategic bet on tokenized gold.
Oxford Square Capital reported a sharp decline in its Net Asset Value (NAV) for the fourth quarter on Tuesday, as significant unrealized depreciation in its investment portfolio overshadowed steady net investment income.
L.B. Foster (NASDAQ:FSTR) reported a mixed fourth quarter on Tuesday, as higher-than-expected revenue from its rail and infrastructure segments failed to translate into the bottom-line performance anticipated by Wall Street.
CalciMedica (NASDAQ:CALC) reported its full-year 2025 financial results on Tuesday, outlining a path forward for its lead candidate, Auxora™, despite the recent discontinuation of its primary kidney injury study.
SOPHiA GENETICS (NASDAQ:SOPH) reported a strong finish to its fiscal year on Tuesday, pairing double-digit revenue growth with significant margin expansion as the healthcare-tech firm moves closer to its goal of operational profitability.
Scholar Rock (NASDAQ:SRRK) reported a significant increase in annual spending on Tuesday, reflecting the heavy operational costs of transitioning from a purely clinical-stage firm to a commercial-ready biopharmaceutical entity.
Versant Media Group (NASDAQ:VSNT) marked its first full year as an independent company by initiating an aggressive capital return program, signaling confidence in its cash-generation even as it navigates a transition away from former parent Comcast.
Viking Holdings (NYSE:VIK) reported a surge in full-year profitability on Tuesday, bolstered by an aggressive fleet expansion and a luxury travel boom that has already filled the vast majority of its 2026 sailing schedule.
Best Buy (NYSE:BBY) reported fourth-quarter earnings that cleared Wall Street’s profitability hurdles on Tuesday, though a slight revenue miss highlighted the continued caution of consumers regarding big-ticket electronics.
